Elderberry for Anti-Inflammatory

Research suggests that elderberry (Sambucus nigra) possesses meaningful anti-inflammatory properties, supported by a consistent body of laboratory and animal studies showing that its bioactive compounds — particularly anthocyanins and other polyphenols — can reduce inflammatory markers such as nitric oxide, pro-inflammatory cytokines like IL-6 and TNF-α, and oxidative stress indicators across multiple cell types and experimental models. Studies indicate these effects operate through several molecular pathways, including inhibition of inflammatory enzymes, modulation of immune cell signaling, and upregulation of antioxidant proteins like Nrf2, with supportive findings spanning skin cells, brain tissue, and immune cells. The available evidence comes primarily from in vitro cell studies, animal experiments, and narrative or systematic reviews, with multiple reviews noting that human clinical trials remain limited in number and quality, making it difficult to draw firm conclusions about how these findings translate to people. A small number of randomized trials have examined elderberry in the context of respiratory illness, finding uncertain but generally encouraging results without evidence of harmful immune overstimulation, though reviewers consistently call for more rigorous clinical research before broad claims about elderberry's anti-inflammatory benefits in humans can be substantiated.